2018 Article Archive
Researchers at UT Southwestern have identified blood-based biomarkers that may help identify those patients at greatest risk of developing autoimmune side effects from the treatment.
Biophysicist Dr. Michael Rosen – whose research is at the forefront of work revealing the fundamental process of protein phase transitions within the cell – today became UT Southwestern’s first Allen Distinguished Investigator.
Dr. W. P. Andrew Lee, a world leader in hand transplantation at Johns Hopkins University School of Medicine, will become the new Executive Vice President for Academic Affairs, Provost, and Dean, UT Southwestern Medical School, effective Feb. 4, 2019.
First large-scale study establishes guidelines for measuring blood pressure at home in U.S. patients
A new study of measuring blood pressure at home in U.S. populations has found that the ideal level is 130 over 80 or lower.
New research in mice indicates the window for autism recovery may be quite lengthy, extending from infancy well into adulthood.
A potential treatment for acute myeloid leukemia, or AML, attacks a harmful molecule found on the cancerous cells and reactivates the body’s white blood cells to fight them.
UT Southwestern researchers have made a major advance in uncovering the biology of how thousands of disfiguring skin tumors occur in patients troubled by a genetic disorder called neurofibromatosis type 1 (NF1). This scientific advance could slow the development of these tumors.
Charis Curbo says most of the time she doesn’t think about her NF1 and the thousands of tumors coating her back, her trunk, and other areas of her skin.
Blue Cross and Blue Shield of Texas and Southwestern Health Resources announce Accountable Care Organization (ACO) agreement
Blue Cross and Blue Shield of Texas (BCBSTX) and Southwestern Health Resources have joined forces to provide access to high-quality and lower cost care. This includes services and enhanced coordination of care for more than 130,000 BCBSTX members across North Texas.
UT Southwestern biochemist Dr. Zhijian “James” Chen today was named winner of the prestigious 2019 Breakthrough Prize in Life Sciences for his discovery of the cGAS enzyme that launches the body’s immune defense against infections and cancers.